In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ono Pharmaceutical Company, Ltd.

https://www.ono-pharma.com

Latest From Ono Pharmaceutical Company, Ltd.

Deal Watch: Gilead Grows Oncology, Inflammation Pipeline With XinThera Buy

The XinThera deal gives Gilead multiple PARP1 and MK2 inhibitors. Also, Roche licenses a HER2 kinase inhibitor from Zion, Amgen partners with TScan in Crohn’s disease and Baxter sells the last of its biopharma operations – a CDMO business – for $4.5bn.

Deal Watch M & A

Oncology’s Hold Over The Pharma Pipeline Increases As Growth Slows

The rate of growth of the pharma pipeline slowed last year as oncology and rare diseases tightened their grip on R&D. There are also further signs of China’s rise in importance in the industry.

Companies Clinical Trials

Record Sales For US, Canada Hydralyte Marketer Remain Under Brand's International Shadow

Hydration Pharmaceuticals Company’s Hydralyte revenues come from limited footprint in rapidly growing sports beverage market while Prestige Consumer Healthcare’s Hydralyte footprint is limited only by not competing with Hydration Pharmaceuticals in US and Canada.

Dietary Supplements Sales & Earnings

Prestige Consumer Not Thirsty For Bringing International Sales Leader Hydralyte To US

Expanding Hydralyte sales to US sports beverage market might seem a likely target for PCH. But firm doesn’t plan to bring its Hydralyte products to the US, where a smaller company owns and markets the brand.

Sales & Earnings OTC Drugs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • Ono Pharma Korea Co., Ltd., Ono Venture Investment Fund I, L.P., Ono Venture Investment, Inc., Ono Pharma UK Ltd.
    • Ono Pharmaceutical Co., Ltd.
    • Ono Pharma Taiwan Co., Ltd.
UsernamePublicRestriction

Register